Malignant peripheral nerve sheath tumor causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Marjan Khan (talk | contribs) No edit summary |
||
(10 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Malignant peripheral nerve sheath tumor}} | {{Malignant peripheral nerve sheath tumor}} | ||
{{CMG}}; {{AE}} {{Marjan}} | |||
==Overview== | |||
Malignant peripheral nerve sheath tumor may be caused by a mutation in the [[neurofibromatosis type I]] gene.<ref name=albright>{{cite book | last = Albright | first = A | title = Principles and practice of pediatric neurosurgery | publisher = Thieme | location = New York | year = 2008 | isbn = 1588903958 }}</ref><ref name=ferrari>{{cite journal|last=Ferrari|first=Andrea|author2=Gianni Bisogno |author3=Modesto Carli |title=Management Of Childhood Malignant Peripheral Nerve Sheath Tumor | journal=Pediatric Drugs | date=2007|volume=9|issue=4|pages=239–48|accessdate=5 Mar 2014 | pmid=17705563 | doi=10.2165/00148581-200709040-00005}}</ref> | |||
==Causes== | |||
* Malignant peripheral nerve sheath tumor may be caused by a mutation in the [[neurofibromatosis type I]] gene.<ref name=albright>{{cite book | last = Albright | first = A | title = Principles and practice of pediatric neurosurgery | publisher = Thieme | location = New York | year = 2008 | isbn = 1588903958 }}</ref><ref name=ferrari>{{cite journal|last=Ferrari|first=Andrea|author2=Gianni Bisogno |author3=Modesto Carli |title=Management Of Childhood Malignant Peripheral Nerve Sheath Tumor | journal=Pediatric Drugs | date=2007|volume=9|issue=4|pages=239–48|accessdate=5 Mar 2014 | pmid=17705563 | doi=10.2165/00148581-200709040-00005}}</ref> | |||
* About half of the cases of malignant peripheral nerve sheath tumor (MPNST) occur along with [[NF1]]. The lifetime risk of having both of these conditions is at 8–13% while those with only MPNST have a 0.001% in the general population.<ref name=ferrari>{{cite journal|last=Ferrari|first=Andrea|author2=Gianni Bisogno |author3=Modesto Carli |title=Management Of Childhood Malignant Peripheral Nerve Sheath Tumor | journal=Pediatric Drugs | date=2007|volume=9|issue=4|pages=239–48|accessdate=5 Mar 2014 | pmid=17705563 | doi=10.2165/00148581-200709040-00005}}</ref> | |||
* The [[NF1]] gene locus is on chromosome 17q11.2 and the gene product is [[neurofibromin]], which acts as a tumor suppressor. Inactivation of the gene predisposes to [[tumor]] development.<ref name=albright>{{cite book | last = Albright | first = A | title = Principles and practice of pediatric neurosurgery | publisher = Thieme | location = New York | year = 2008 | isbn = 1588903958 }}</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Line 8: | Line 18: | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 13:20, 23 August 2019
Malignant peripheral nerve sheath tumor Microchapters |
Differentiating Malignant Peripheral Nerve Sheath Tumor from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Malignant peripheral nerve sheath tumor causes On the Web |
American Roentgen Ray Society Images of Malignant peripheral nerve sheath tumor causes |
Directions to Hospitals Treating Malignant peripheral nerve sheath tumor |
Risk calculators and risk factors for Malignant peripheral nerve sheath tumor causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marjan Khan M.B.B.S.[2]
Overview
Malignant peripheral nerve sheath tumor may be caused by a mutation in the neurofibromatosis type I gene.[1][2]
Causes
- Malignant peripheral nerve sheath tumor may be caused by a mutation in the neurofibromatosis type I gene.[1][2]
- About half of the cases of malignant peripheral nerve sheath tumor (MPNST) occur along with NF1. The lifetime risk of having both of these conditions is at 8–13% while those with only MPNST have a 0.001% in the general population.[2]
- The NF1 gene locus is on chromosome 17q11.2 and the gene product is neurofibromin, which acts as a tumor suppressor. Inactivation of the gene predisposes to tumor development.[1]
References
- ↑ 1.0 1.1 1.2 Albright, A (2008). Principles and practice of pediatric neurosurgery. New York: Thieme. ISBN 1588903958.
- ↑ 2.0 2.1 2.2 Ferrari, Andrea; Gianni Bisogno; Modesto Carli (2007). "Management Of Childhood Malignant Peripheral Nerve Sheath Tumor". Pediatric Drugs. 9 (4): 239–48. doi:10.2165/00148581-200709040-00005. PMID 17705563.
|access-date=
requires|url=
(help)